Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM

A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM"

Post a Comment